Age
Item
18 years of age or older
boolean
C0001779 (UMLS CUI [1])
Ecog
Item
ecog 0-2
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
life expectancy of at least 12 weeks
boolean
C0023671 (UMLS CUI [1])
metastatic colorectal cancer
Item
pathologically confirmed diagnosis of metastatic colorectal cancer
boolean
C0009402 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
measureable disease
Item
measureable disease
boolean
C1513041 (UMLS CUI [1])
prior therapy
Item
have not received therapy for cancer within 4 weeks of enrollment on study
boolean
C1514463 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
prior radiation therapy
Item
prior radiation therapy to the pelvis for treatment of colorectal cancer is allowed. radiation therapy delivered elsewhere is allowed as long as the patient has been off treatment for at least six weeks and measurable lesions are present outside the radiation field
boolean
C1522449 (UMLS CUI [1])
C0221198 (UMLS CUI [2,1])
C1513040 (UMLS CUI [2,2])
granulocyte count, hemoglobin, platelet count
Item
pretreatment granulocyte count of > 1500/mm3, hemoglobin > 9.0 g/dl (without transfusion), and platelet count of > 100,000/um
boolean
C0857490 (UMLS CUI [1])
C0019046 (UMLS CUI [2])
C0005821 (UMLS CUI [3])
serum creatinine
Item
serum creatinine < 2.0 mg/dl
boolean
C0201976 (UMLS CUI [1])
liver function, serum bilirubin, ast
Item
adequate hepatic function as documented by a serum bilirubin < 2.0 mg/dl regardless of whether patients have liver involvement secondary to tumor. ast must be < 3x the upper limit of normal unless the liver is involved with tumor, in which case the ast must be < 5x institutional upper limit of normal
boolean
C0232741 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
irinotecan
Item
prior therapy with irinotecan
boolean
C0123931 (UMLS CUI [1])
active or uncontrolled infection
Item
patients with any active or uncontrolled infection
boolean
C0009488 (UMLS CUI [1])
psychiatric disorders that would interfere with consent or follow-up
Item
patients with psychiatric disorders that would interfere with consent or follow-up
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0004936 (UMLS CUI [1,3])
myocardial infarction, congestive heart failure or cerebrovascular disease
Item
patients with a history of myocardial infarction within the previous six months, congestive heart failure, or cerebrovascular disease
boolean
C0027051 (UMLS CUI [1])
C0007820 (UMLS CUI [2])
C0018802 (UMLS CUI [3])
malignancies
Item
history of prior malignancy except for adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, or other cancer for which the patient has been disease-free for at least five years
boolean
C0006826 (UMLS CUI [1])
C0553723 (UMLS CUI [2])
C0007117 (UMLS CUI [3])
C0302592 (UMLS CUI [4,1])
C0007099 (UMLS CUI [4,2])
cns metastases, carcinomatous meningitis
Item
presence of clinically apparent central nervous system metastases or carcinomatous meningitis
boolean
C0686377 (UMLS CUI [1])
C0220654 (UMLS CUI [2])
uncontrolled diabetes mellitus
Item
patients with uncontrolled diabetes mellitus
boolean
C0011849 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
concurrent disease which would make the patient inappropriate for entry into this study
Item
any other sever concurrent disease which, in the judgment of the investigator, would make the patient inappropriate for entry into this study
boolean
C0009488 (UMLS CUI [1])
antihypertensive medication,
Item
patients unable to stop taking antihypertensive medication 24 hour prior to administration of ethyol (off x 1 day)
boolean
C0003364 (UMLS CUI [1])
C0015020 (UMLS CUI [2])